Decoding Cancer's DNA to find the right drug
NCT ID NCT02155621
Summary
This study aims to improve treatment for people with advanced or metastatic cancer by analyzing the unique genetic makeup of their tumor. Researchers will sequence the DNA and RNA from a patient's tumor and blood sample to identify genetic 'drivers' of the cancer. The goal is to use this information to recommend specific targeted therapies or match patients to relevant clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
BC Cancer Agency
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.